Treatment outcomes of infants with cyanotic congenital heart disease treated with synbiotics

Pediatrics

Volumn 132, Issue 4, 2013, Pages

  Dilli, Dilek ^a,b   Aydin, Banu ^a   Zenciroglu, Aysegül ^a   Özyazici, Elif ^a   Beken, Serdar ^a   Okumus, Nurullah ^a  

^a Dr Sami Ulus Maternity and Children Training and Research Hospital   (Turkey)

^b Yenidǒgan Kliniǧi ^*  (Turkey)

Author keywords

Cyanotic congenital heart disease; Necrotizing enterocolitis; Sepsis; Synbiotics

Indexed keywords

EID: 84885164250     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1262     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention (CDC). Racial differences by gestational age in neonatal deaths attributable to congenital heart defects-United States, 2003-2006. MMWR Morb Mortal Wkly Rep. 2010;59(37): 1208-1211
2. Elward AM, Fraser VJ. Risk factors for nosocomial primary bloodstream infection in pediatric intensive care unit patients: a 2-year prospective cohort study. Infect Control Hosp Epidemiol. 2006;27(6):553-560
3. Lambert DK, Christensen RD, Henry E, et al. Necrotizing enterocolitis in term neonates: data from a multihospital health-care system. J Perinatol. 2007;27(7):437-443
4. McElhinney DB, Hedrick HL, Bush DM, et al. Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. Pediatrics. 2000;106(5):1080-1087
5. Ellis CL, Rutledge JC, Underwood MA. Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart disease. Gut Microbes. 2010;1(6):359-366
6. Giannone PJ, Luce WA, Nankervis CA, Hoffman TM, Wold LE. Necrotizing enterocolitis in neonates with congenital heart disease. Life Sci. 2008;82(7-8):341-347
7. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009; 136(1):65-80
8. Rabot S, Rafter J, Rijkers GT, Watzl B, Antoine JM. Guidance for substantiating the evidence for beneficial effects of probiotics: impact of probiotics on digestive system metabolism. J Nutr. 2010;140(3): 677S-689S
9. Haque KN. Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med. 2005;6(suppl 3):S45-S49
10. Walsh MC, Kliegman RM, Fanaroff AA. Necrotizing enterocolitis: a practitioner's perspective. Pediatr Rev. 1988;9(7):219-226
11. Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr. 2001;138(1):92-100
12. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002;123(1):110-118
13. Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg. 2012;47(1):241-248
14. Szajewska H. Probiotics and prebiotics in preterm infants: where are we? Where are we going? Early Hum Dev. 2010;86(1 suppl 1):81-86
15. Ellis CL, Bokulich NA, Kalanetra KM, et al. Probiotic administration in congenital heart disease: a pilot study [published online ahead of print April 18, 2013]. J Perinatol. doi:doi:10.1038/jp.2013.41
16. Clark R, Powers R, White R, Bloom B, Sanchez P, Benjamin DK Jr. Nosocomial infection in the NICU: a medical complication or unavoidable problem? J Perinatol. 2004;24(6): 382-388
17. Abou Elella R, Najm HK, Balkhy H, Bullard L, Kabbani MS. Impact of bloodstream infection on the outcome of children undergoing cardiac surgery. Pediatr Cardiol. 2010;31(4):483-489
18. Prasad PA, Dominguez TE, Zaoutis TE, et al. Risk factors for catheter-associated bloodstream infections in a Pediatric Cardiac Intensive Care Unit. Pediatr Infect Dis J. 2010;29(9):812-815
19. Levy I, Ovadia B, Erez E, et al. Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors. J Hosp Infect. 2003;53(2):111-116
20. Ascher SB, Smith PB, Clark RH, et al. Sepsis in young infants with congenital heart disease. Early Hum Dev. 2012;88(suppl 2): S92-S97
21. Hatakka K, Saxelin M. Probiotics in intestinal and non-intestinal infectious diseases-clinical evidence. Curr Pharm Des. 2008;14(14):1351-1367
22. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2011;(3):CD005496
23. Srinivasjois R, Rao S, Patole S. Prebiotic supplementation of formula in preterm neonates: a systematic review and metaanalysis of randomised controlled trials. Clin Nutr. 2009;28(3):237-242
24. Rojas MA, Lozano JM, Rojas MX, et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics. 2012;130(5): Available at: www.pediatrics.org/cgi/content/full/130/5/e1113
25. Hebra A, Brown MF, Hirschl RB, et al. Mesenteric ischemia in hypoplastic left heart syndrome. J Pediatr Surg. 1993;28(4):606-611
26. Kargl S, Maier R, Gitter R, Pumberger W. Necrotizing enterocolitis after open cardiac surgery for congenital heart defects-a serious threat. Klin Padiatr. 2013;225(1): 24-28
27. Sweet DG, Craig B, Halliday HL, Mulholland C. Gastro-intestinal complications following neonatal cardiac catheterisation. J Perinat Med. 1998;26(3):196-200
28. Lindinger A, Schwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany: results of the first registration year of the PAN Study (July 2006 to June 2007). Klin Padiatr. 2010;222 (5):321-326
29. Kalfa D, Charpentier A, Dragulescu A, et al. Ischaemic intestinal disease in neonates with congenital heart defects: the timing of cardiac surgery does matter. Arch Dis Child Fetal Neonatal Ed. 2010;95(1):F75-F76